Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Invictus Secures Sales License & Updates Nasdaq Application

Stockhouse Editorial
0 Comments| January 21, 2019

{{labelSign}}  Favorites
{{errorMessage}}

Invictus MD Strategies Corp. (V.GENE, V.GENE.WT, Forum) announced on Monday that its wholly-owned subsidiary Canandia has received a sales license from Health Canada for its Delta location, which includes a cultivation, production and research facility.

For more details on this, click here.

Invictus also stated on Mondaythat it will go ahead with a consolidation of its issued and outstanding shares in connection with its proposed listing on Nasdaq Stock Market LLC.


FULL DISCLOSURE: Invictus MD Strategies Corp. is a client of Stockhouse Publishing.



{{labelSign}}  Favorites
{{errorMessage}}

Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today

Featured Company